Compare Extra Space Storage, Inc. (EXR) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs Summit Therapeutics Inc — how do they compare? Extra Space Storage, Inc. trades at $134.65 (market cap $28.12B), while Summit Therapeutics Inc trades at $17.59 (market cap $13.71B). The key difference: Extra Space Storage, Inc. is far larger — about 2.1× Summit Therapeutics Inc's market cap, and Extra Space Storage, Inc. pays a 4.87% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and Summit Therapeutics Inc for 16 Days on average.
| EXR | SMMT | |
|---|---|---|
Market Cap | $28.12B | $13.71B |
Volume | 2,595,579 | 6,173,057 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $26.38 |
52-Week Low | $126.67 | $12.43 |
Typical Hold Time | 109 Days | 16 Days |
Enterprise Value | $41.84B | $13.04B |
Dividend Yield | 4.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXR trades at $133.12, up 1.08% today, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38B in 2025, and net income margin remains healthy at 27.79%. Analyst consensus is split evenly between Buy and Hold, with a price target of $158.33 implying upside. Recent news highlights leadership transition and positive operational performance.
The outlook is balanced: solid profitability and growth support upside, but high valuation multiples and bearish technicals pose near-term risks. Key catalysts include Q3 earnings and execution under new leadership. Risks involve interest rate sensitivity and competitive pressures in the REIT sector.
Summit Therapeutics (SMMT) trades at $17.59, down 2.01% on the day, amid mixed earnings performance but strong analyst support with a consensus price target of $29.33. The stock shows a bullish technical signal from moving averages, with key support at $17 and resistance at $18. Recent news highlights a major $2 billion strategic investment from AstraZeneca and expanded clinical collaborations, boosting investor optimism despite current negative profitability metrics.
The outlook for SMMT is heavily driven by clinical progress and partnerships, offering significant upside if drug trials succeed, but carries high risk due to substantial losses, negative cash flow from operations, and reliance on positive trial outcomes. Investors should weigh the potential rewards against the company's current financial health and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
